杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Nov 30 2022

Full Issue

Spreading Covid Misinformation On Twitter No Longer Banned

Elon Musk's Twitter has stopped all efforts to monitor and catch disinformation about covid or vaccines posted on its social media platform, according to an update of its policies.

Twitter will no longer stop users from spreading false information about the Covid-19 virus or vaccines, according to an update on its content moderation policies. It鈥檚 another major shift under new owner Elon Musk, who has pressed for 鈥渇ree speech鈥 above all else on the platform. Twitter鈥檚 Covid-19 misinformation page was updated with a note saying that as of Nov. 23, the platform would no longer enforce its policies against spreading misleading information on the virus and vaccines 鈥 which had led to more than 11,000 account suspensions since 2020. (Kern, 11/29)

However, Twitter has also struggled to police misinformation accurately and recently began labeling some factual information about covid as misinformation and banning scientists and researchers who attempted to warn the public of the long-term harm of covid on the body. As of last weekend, many tweets promoting anti-vaccine content and covid misinformation remained on the platform. (Lorenz, 11/29)

By Tuesday, some Twitter accounts were testing the new boundaries and celebrating the platform鈥檚 hands-off approach, which comes after Twitter was purchased by Elon Musk. 鈥淭his policy was used to silence people across the world who questioned the media narrative surrounding the virus and treatment options,鈥 tweeted Dr. Simone Gold, a physician and leading purveyor of COVID-19 misinformation. (Klepper, 11/29)

鈥淚 am absolutely terrified and despondent,鈥 said Peter Chin-Hong, an infectious disease expert with UCSF. 鈥淧ermitting misinformation is not just about freedom of speech. There is a direct pathway between misinformation and death if science-based interventions like vaccines are not embraced.鈥 (Vaziri and Hwang, 11/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 1
  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
  • Friday, May 22
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF